Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Evangelos Karamatskos, Martin Lambert, Christoph Mulert & Dieter Naber. (2012) Drug safety and efficacy evaluation of sertindole for schizophrenia. Expert Opinion on Drug Safety 11:6, pages 1047-1062.
Read now
Read now
Articles from other publishers (15)
Tevfik Kalelioglu, Nesrin Karamustafalioglu, Murat Emul, Guler Celikel, İpek Ozonder, Aysu Kara, Cenk Kilic, Suat Yalcin, Ecem Celik, Ugur Kilic, Ahoora Ladoni, Emma Ragone, Caroline Centeno & J. Kim Penberthy. (2023) Detecting biomarkers associated with antipsychotic-induced extrapyramidal syndromes by using machine learning techniques. Journal of Psychiatric Research 158, pages 300-304.
Crossref
Crossref
Palmiero Monteleone, Giammarco Cascino, Alessandro Rossi, Paola Rocca, Alessandro Bertolino, Eugenio Aguglia, Mario Amore, Ileana Andriola, Antonello Bellomo, Massimo Biondi, Claudio Brasso, Bernardo Carpiniello, Enrico Collantoni, Liliana Dell'Osso, Massimo di Giannantonio, Michele Fabrazzo, Andrea Fagiolini, Giulia Maria Giordano, Matteo Marcatili, Carlo Marchesi, Alessio Maria Monteleone, Maurizio Pompili, Rita Roncone, Alberto Siracusano, Antonio Vita, Patrizia Zeppegno, Silvana Galderisi & Mario Maj. (2022) Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study. Schizophrenia Research 248, pages 279-286.
Crossref
Crossref
Chizimuzo T.C. Okoli, Amani Kappi, Tianyi Wang, Andrew Makowski & Andrew T. Cooley. (2021) The effect of long‐acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review and meta‐analysis. International Journal of Mental Health Nursing 31:3, pages 469-535.
Crossref
Crossref
Abdulkarim M. Meraya, Otilia J.F. Banji, Moteb A. Khobrani & Abdulaziz Alhossan. (2021) Evaluation of psychotropic medications use among elderly with psychiatric disorders in Saudi Arabia. Saudi Pharmaceutical Journal 29:6, pages 603-608.
Crossref
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M Kane & Christoph U Correll. (2021) Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies. The Lancet Psychiatry 8:5, pages 387-404.
Crossref
Crossref
Satoshi Ninagawa, Seiichiro Tada, Masaki Okumura, Kenta Inoguchi, Misaki Kinoshita, Shingo Kanemura, Koshi Imami, Hajime Umezawa, Tokiro Ishikawa, Robert B Mackin, Seiji Torii, Yasushi Ishihama, Kenji Inaba, Takayuki Anazawa, Takahiko Nagamine & Kazutoshi Mori. (2020) Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes. eLife 9.
Crossref
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Masahiro Nitta, Stefan Leucht, Mark Olfson, John M Kane & Christoph U Correll. (2018) Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies. Schizophrenia Bulletin 44:3, pages 603-619.
Crossref
Crossref
Arka Chattopadhyay, Stephen Frey & Ghiselle Green. (2016) Bifeprunox versus placebo for schizophrenia. Cochrane Database of Systematic Reviews 2016:10.
Crossref
Crossref
Arka Chattopadhyay, Stephen Frey, Ghiselle Green, Alexandra Harkness, Alice McDermott & Anna Yates. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Leon Tourian & Howard C Margolese. (2013) Extended-release intramuscular aripiprazole for maintenance pharmacotherapy in schizophrenia and related disorders. Neuropsychiatry 3:3, pages 345-354.
Crossref
Crossref
Giuseppe Rossi, Sonia Frediani, Roberta Rossi & Andrea Rossi. (2012) Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations. BMC Psychiatry 12:1.
Crossref
Crossref
Michael Levine & Anne-Michelle Ruha. (2012) Overdose of Atypical Antipsychotics. CNS Drugs 26:7, pages 601-611.
Crossref
Crossref
David P. McDonnell, Ludmila A. Kryzhanovskaya, Fangyi Zhao, Holland C. Detke & Peter D. Feldman. (2011) Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long‐acting injection versus oral olanzapine. Human Psychopharmacology: Clinical and Experimental 26:6, pages 422-433.
Crossref
Crossref
Pamela L. Lindsey. (2009) Psychotropic Medication Use Among Older Adults: What All Nurses Need to Know. Journal of Gerontological Nursing 35:9, pages 28-38.
Crossref
Crossref
Daniel E. Casey, Earl E. Sands, Jens Heisterberg & Hwa-Ming Yang. (2008) Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study. Psychopharmacology 200:3, pages 317-331.
Crossref
Crossref